CAS 669089-53-6

Urantide acetate (free base)

CAS : 669089-53-6

Urantide acetate (free base)

Couleur et forme : Solid

Masse moléculaire : 1,075.26g/mol

Ref: 54-BI4547

Urantide

CAS : 669089-53-6

Urantideâ„¢ is a peptide that is derived from Urotensin II and related peptides. It has been shown to be an antagonist of the urotensin receptor, which may be involved in the regulation of renal function. The peptide inhibits the release of renin, aldosterone, and vasopressin.

Formule : C₅₁H₆₆N₁₀O₁₂S₂

Degré de pureté : Min. 95%

Masse moléculaire : 1,075.28 g/mol

Ref: 3D-PUT-3639-PI

Urantide

CAS : 669089-53-6

UT receptor antagonist with pKB of 8.3; inhibits hU-II in aorta, no impact on other contractions/relaxations; partial agonist in Ca2+ assay.

Formule : C₅₁H₆₆N₁₀O₁₂S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 1075.26

Ref: TM-TP2106

Urantide

CAS : 669089-53-6

Urantide is a drug that has been shown to bind to the cytosolic Ca2+ receptor, which is a protein found on the surface of cells. Urantide binds to this receptor and activates it. The activated Ca2+ receptor in turn triggers a series of reactions that lead to increased levels of urantide, which is a naturally occurring hormone in the body. Urantide has also been shown to bind to a specific protein called urotensin, which is involved in regulating blood pressure by causing vasoconstriction. The drug is being studied as an effective treatment for myocardial infarcts and other models of ischemia-reperfusion injury. It may also be used as a potential treatment for hepatic steatosis (fatty liver disease).

Formule : C₅₁H₆₆N₁₀O₁₂S₂

Degré de pureté : Min. 95%

Masse moléculaire : 1,075.3 g/mol

Ref: 3D-UBB08953